The application of these properties to develop PrPC-based therapies may lead to innovative approaches that could compensate or overcome the limitations of the currently available treatment options for many kidney diseases, including acute kidney injury, chronic kidney disease, renal fibrosis, and renal cancer (Table 1). This evidence concerns the gene PRNP and renal fibrosis.